This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
Mr. Healy will focus on sales-related activities to drive the company's efforts to grow within the pharmaceutical clinical trials and drug distribution arenas. He will report directly to Andrew J. Mills, CEO Americas & Global Head of Sales for Intelsius.
"We are looking forward to having someone with Steve's extensive industry experience bring his outstanding skills to our company," said Mills. "He has excellent leadership skills and a proven track record of exceeding sales goals while providing strategic customer service. His former clients praise Steve for consistently great results and describe him as an expert - making him a great fit for Intelsius."
Prior to joining Intelsius, Healy held high-level sales and marketing management positions at another company in the temperature controlled packaging industry.
"As the infrastructure continues to grow to support its global business, I look forward to using my knowledge to protect patient safety and propel continuing growth at Intelsius," said Healy. "I am delighted to join the company during its 15(th) anniversary celebration and look forward to the innovative solutions and services that will be introduced this year."
Intelsius introduced the ORCA(TM) 2.0 range of high performance solutions last month at the IQPC Cool Chain Logistics conference in Basel, Switzerland. The ORCA 2.0 range utilises proprietary Plantol(TM) Phase Change Material that allows for 170 plus hours of superior thermal protection for high value, temperature sensitive payloads.
Intelsius serves a wide range of organisations, including government agencies, leading pharmaceutical companies, biopharmaceutical and clinical research industries to major laboratories and life sciences organisations. Intelsius provides intelligent, thoroughly tested and qualified packaging systems that meet regulatory compliance standards worldwide.